- Topic
396 Popularity
8k Popularity
5k Popularity
3k Popularity
35k Popularity
19k Popularity
23k Popularity
11k Popularity
2k Popularity
7k Popularity
- Pin
- 🎉 [Gate 30 Million Milestone] Share Your Gate Moment & Win Exclusive Gifts!
Gate has surpassed 30M users worldwide — not just a number, but a journey we've built together.
Remember the thrill of opening your first account, or the Gate merch that’s been part of your daily life?
📸 Join the #MyGateMoment# campaign!
Share your story on Gate Square, and embrace the next 30 million together!
✅ How to Participate:
1️⃣ Post a photo or video with Gate elements
2️⃣ Add #MyGateMoment# and share your story, wishes, or thoughts
3️⃣ Share your post on Twitter (X) — top 10 views will get extra rewards!
👉
- GT Airdrop Is Live! 1.92M GT Burned in Q2, Worth Over $39M
🎁 Complete simple tasks, get up to 13.2 GT per user
📅 From July 8 to July 20
👉 Join now + trade futures to qualify: https://www.gate.com/campaigns/1431
- 📢 #Gate Square Writing Contest Phase 1# is now officially launched!
Share your unique insights on the CROSS project and stand a chance to win $500 worth of CROSS rewards!
💰 Rewards:
1st Prize (1 winner): $150 worth of CROSS
2nd Prize (3 winners): $50 worth of CROSS each
3rd Prize (10 winners): $20 worth of CROSS each
👉 How to Participate:
1. Publish your unique insights on the CROSS project in Gate Square.
2. Add the tag #Gate Square Writing Contest Phase 1# to your post (minimum of 300 words).
3. Share your article or insights on X with the tags: Gate Square & CROSS.
Essay Content Directio
- 🎉 #Gate xStocks Trading Share# Posting Event Is Ongoing!
📝 Share your trading experience on Gate Square to unlock $1,000 rewards!
🎁 5 top Square creators * $100 Futures Voucher
🎉 Share your post on X – Top 10 posts by views * extra $50
How to Participate:
1️⃣ Follow Gate_Square
2️⃣ Make an original post (at least 20 words) with #Gate xStocks Trading Share#
3️⃣ If you share on Twitter, submit post link here: https://www.gate.com/questionnaire/6854
Note: You may submit the form multiple times. More posts, higher chances to win!
📅 End at: July 9, 16:00 UTC
Show off your trading on Gate Squ
Bai Aotai: Signed authorization, production, supply, and commercialization protocol for BAT2306 (sukunumab) injection with Stein.
On December 16th, Jinshi Data News, the company signed an authorization license with SteinCares for the production, supply, and commercialization of the protocol, granting Stein the exclusive commercialization rights for the company's BAT2306 (Sikuchenyou monoclonal antibody) injection solution in the Brazilian and other Latin American markets. The transaction amount is up to a maximum of $8 million, including a $1.2 million down payment, a cumulative milestone payment of no more than $6.8 million, and a double-digit percentage of net sales as revenue sharing.